Among the 187 patients, 149 were estrogen receptor (ER)‐positive, based on immunohistochemical analysis of the primary tumor, highlighting the prevalence of ER‐positive disease in breast cancer with bone metastasis. Here, ESR1 is linked to breast cancer.